SUBSCRIBE
SUBSCRIBE

Sound Pharmaceuticals

NEWS
Drug Development
2021 COVID-19 News: Breakthrough Cases, Children’s Viral Load and More
Please check out the biopharma industry’s COVID-19 stories that are trending for April 13, 2021.
April 13, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
bakdc/Shutterstock
Drug Development
NIH to Back First Phase II Trials for COVID-19 Therapy Targeting Viral Proteases
The $3.1 million NCATS grant will help the company test SPI-1005 in two trials, both OK’d by the U.S. Food and Drug Administration (FDA) last August.
April 7, 2021
 · 
2 min read
 · 
Mark Zipkin
IN THE PRESS
BioForest
Sound Pharmaceuticals, Inc. Announces $1.6 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Prevent And Treat The Hearing Loss And Tinnitus Associated With Antibiotic Use
March 21, 2017
 · 
2 min read
Business
Sound Pharmaceuticals, Inc. Announces Two New Executive Hires To Accelerate Its Meniere’s Drug Development Program
November 1, 2016
 · 
2 min read
Business
Sound Pharmaceuticals, Inc. And DoD Collaborate On New Hearing Loss Guidance
September 7, 2016
 · 
2 min read
BioForest
Sound Pharmaceuticals, Inc. To Present At The 15th Annual Needham & Company Healthcare Conference
April 4, 2016
 · 
1 min read
Business
Sound Pharmaceuticals, Inc. Announces Appointment Of Paul Rickey As Chief Financial Officer
March 16, 2016
 · 
2 min read
Business
Sound Pharmaceuticals, Inc. And University of Oxford Collaborate On A New Treatment For Bipolar Disorder
March 9, 2016
 · 
2 min read
Drug Development
FDA Allows Sound Pharmaceuticals, Inc. To Begin Meniere’s Disease Clinical Trial
January 5, 2016
 · 
1 min read
Drug Development
Sound Pharmaceuticals, Inc. Submits Positive Phase 2 Clinical Trial Data On SPI-1005 For The Prevention And Treatment Of Sensorineural Hearing Loss
February 18, 2014
 · 
2 min read
Drug Development
Sound Pharmaceuticals, Inc. Successfully Completes Its First Phase 2 Clinical Trial With SPI-1005 Involving iPod® or Noise Induced Hearing Loss
November 5, 2013
 · 
1 min read
Drug Development
Sound Pharmaceuticals, Inc. Release: University of Florida Begins iPod® Trial With SPI-1005 to Prevent Hearing Loss
December 6, 2012
 · 
2 min read
Load More
JOBS